Vitrolife Preparing Distribution of the Transplantation Business

Published: Mar 19, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:

Vitrolife AB (publ)(STO:VITR) is today publishing the decision of the Board to begin preparations for a spin-off of the transplantation business, which today is run in the subsidiary Xvivo Perfusion AB. The spin-off will take place through distribution of the shares in the subsidiary in accordance with “Lex Asea”. It is intended that the shares in Xvivo Perfusion AB will be listed on NASDAQ OMX First North in connection with the distribution.

Back to news